Between 15% and 20% of U.S. adults over the age of 65 have obstructive sleep apnea (OSA), according to research in the ...
Nicko displays the device, a Philips DreamStation, to the camera, noting that it has “now been recalled.” He claims this is because the sound-abating foam inside breaks down, “and then it travels into ...
Carbon dioxide (CO2) is a major respiratory metabolite, and continuous monitoring of CO2 concentration in exhaled breath is ...
Kansas' Democratic governor on Tuesday vetoed a proposed Republican-backed ban on gender-affirming care for transgender minors.
The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.
During its fourth-quarter earnings call this week, Inspire Medical disclosed that it has become the subject of a civil probe ...
CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...
Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...
Smart beds with adjustable head positioning, like Tempur-pedic's Tempur-Ergo smart power base and the Eight Sleep Pod 4 Ultra ...
Leerink Partners made a slight adjustment to the price target of Inspire Medical Systems (NYSE:INSP), raising it from $193.00 to $194.00, while keeping a Market Perform rating on the stock. According ...
Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, ...
Inspire (INSP) delivered earnings and revenue surprises of 55.41% and 0.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results